Related references
Note: Only part of the references are listed.Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure
Hitendra Garg et al.
DIGESTIVE AND LIVER DISEASE (2012)
Durability of Rifaximin Response in Hepatic Encephalopathy
Guy W. Neff et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Rifaximin vs conventional oral therapy for hepatic encephalopathy: A meta-analysis
Karim M. Eltawil et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Hepatic Encephalopathy
Wissam Bleibel et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2012)
A Current Review of the Diagnostic and Treatment Strategies of Hepatic Encephalopathy
Z. Poh et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2012)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Pathogenesis and diagnosis of hepatic encephalopathy
Mark J. W. McPhail et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy
Jerome Fichet et al.
JOURNAL OF CRITICAL CARE (2009)
Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations
E. A. Debbia et al.
JOURNAL OF CHEMOTHERAPY (2008)
Rifaximin for the treatment of hepatic encephalopathy
Kenneth R. Lawrence et al.
PHARMACOTHERAPY (2008)
Assessment of low-grade hepatic encephalopathy:: A critical analysis
Gerald Kircheis et al.
JOURNAL OF HEPATOLOGY (2007)
Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease
Charmaine A. Stewart et al.
LIVER TRANSPLANTATION (2007)
Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: A prospective randomized study
YH Paik et al.
YONSEI MEDICAL JOURNAL (2005)
Management of hepatic encephalopathy: Role of rifaximin
ML Zeneroli et al.
CHEMOTHERAPY (2005)
Rifaximin: In vitro and in vivo antibacterial activity - A review
ZD Jiang et al.
CHEMOTHERAPY (2005)
Correlation between ammonia levels and the severity of hepatic encephalopathy
JP Ong et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, doubledummy, controlled clinical trial
A Mas et al.
JOURNAL OF HEPATOLOGY (2003)
Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998
P Ferenci et al.
HEPATOLOGY (2002)
The art of quality assessment of RCTs included in systematic reviews
AP Verhagen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Hepatic encephalopathy - Metabolic consequence of cirrhosis often is reversible
S Abou-Assi et al.
POSTGRADUATE MEDICINE (2001)
Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre study
R Williams et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2000)
Share Paper
